The Food and Drug Administration (FDA) is alerting doctors that it has received several dozen adverse event reports with fluid-filled intragastric balloons used to aid in weight loss of obese patients. Doctors are being advised to closely monitor patients with these devices for adverse events and submit reports to the agency so that investigators can better understand any complications associated with the use of obesity treatment devices. The first type of adverse event involves the fluid-filled gastric balloon over-inflating with air or with more fluid, a condition known as spontaneous hyperinflation, while in the patient’s stomach, leading to the premature removal ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.